Literature DB >> 21880215

Endothelial activation and injury by cigarette smoke exposure.

F Guarino1, G Cantarella, M Caruso, C Russo, S Mancuso, G Arcidiacono, R R Cacciola, R Bernardini, R Polosa.   

Abstract

Endothelial activation/injury following exposure to cigarette smoke may explain incidence of atherosclerosis and cardiovascular disease in smokers. We investigated cigarette smoke extract (CSE) effects relative to activation, injury, and survival of human umbilical vein endothelial cells (HUVEC) and compared circulating levels of specific endothelial activation markers between smokers and healthy non-smokers before and after smoking cessation. Viability and toxicity of HUVEC were tested by MTT and LDH assay. Release (by endothelial cells) and circulating levels (in smokers) of von Willebrand Factor (vWF), thrombomodulin (TM), was evaluated by ELISA. Incubation with increasing concentrations of CSE reduced the percentage of viable cells, being 33.9%, 23.9% after CSE 4%, 6% respectively. Dose- and time-dependent release of LDH was observed after incubation with CSE. vWF, TM release were assayed after CSE 2% HUVEC stimulation. Significant 42%, 61%, 76% increase in vWF concentration was detected respectively at 30', 60', 120'. Reduction in circulating levels of vWF, from a median value of 144.0% to 123.7%, was observed in the quitters group after smoking cessation. Exposure to cigarette smoke is cytotoxic and induces activation/injury of endothelium in vitro and in vivo. These findings may provide pathogenetic basis by which smoking can predispose to development of atherothrombosis and cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21880215

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  11 in total

Review 1.  Impact of stopping smoking on metabolic parameters in diabetes mellitus: A scoping review.

Authors:  Magdalena Walicka; Cristina Russo; Michael Baxter; Isaac John; Grazia Caci; Riccardo Polosa
Journal:  World J Diabetes       Date:  2022-06-15

2.  Endothelial Cell Inflammatory Reactions Are Altered in the Presence of E-Cigarette Extracts of Variable Nicotine.

Authors:  Kirstin E Barber; Berhane Ghebrehiwet; Wei Yin; David A Rubenstein
Journal:  Cell Mol Bioeng       Date:  2016-08-24       Impact factor: 2.321

3.  Nodular glomerulosclerosis with anti-glomerular basement membrane-like glomerulonephritis; a distinct pattern of kidney injury observed in smokers.

Authors:  Ibrahim Batal; Daisy B Reyes; Sandy Popham; Vanesa Bijol
Journal:  Clin Kidney J       Date:  2014-06-26

4.  Non-Smoking Tobacco Affects Endothelial Function in Healthy Men in One of the Largest Health Studies Ever Performed; The Nord-Trøndelag Health Study in Norway; HUNT3.

Authors:  Eli-Anne Skaug; Bjarne Nes; Stian Thoresen Aspenes; Øyvind Ellingsen
Journal:  PLoS One       Date:  2016-08-04       Impact factor: 3.240

5.  International randomised controlled trial evaluating metabolic syndrome in type 2 diabetic cigarette smokers following switching to combustion-free nicotine delivery systems: the DIASMOKE protocol.

Authors:  Arkadiusz Krysinski; Cristina Russo; Sarah John; Jonathan D Belsey; Davide Campagna; Pasquale Caponnetto; Lorina Vudu; Chong Wei Lim; Francesco Purrello; Maurizio Di Mauro; Farrukh Iqbal; David Fluck; Edward Franek; Riccardo Polosa; Pankaj Sharma
Journal:  BMJ Open       Date:  2021-04-27       Impact factor: 2.692

6.  Factors determining outcome of post-angiogram-negative subarachnoid hemorrhage.

Authors:  N Kumar; S Gupta
Journal:  J Postgrad Med       Date:  2021 Oct-Dec       Impact factor: 1.476

Review 7.  Tobacco Use and Periodontal Disease-The Role of Microvascular Dysfunction.

Authors:  Henrique Silva
Journal:  Biology (Basel)       Date:  2021-05-17

8.  Apoptosis and necrosis: two different outcomes of cigarette smoke condensate-induced endothelial cell death.

Authors:  B Messner; S Frotschnig; A Steinacher-Nigisch; B Winter; E Eichmair; J Gebetsberger; S Schwaiger; C Ploner; G Laufer; D Bernhard
Journal:  Cell Death Dis       Date:  2012-11-15       Impact factor: 8.469

9.  Evaluation of von Willebrand factor in COPD patients.

Authors:  Thiago Prudente Bártholo; Cláudia Henrique da Costa; Rogério Rufino
Journal:  J Bras Pneumol       Date:  2014 Jul-Aug       Impact factor: 2.624

10.  A double blind randomized controlled trial investigating efficacy and safety of varenicline for smoking cessation in patients with type 2 diabetes: study protocol.

Authors:  C Russo; P Caponnetto; F Cibella; M Maglia; A Alamo; D Campagna; L Frittitta; M Di Mauro; C Leotta; E Mondati; A Krysiński; E Franek; R Polosa
Journal:  Intern Emerg Med       Date:  2021-03-18       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.